Literature DB >> 6173524

Vagal and sympathetic contributions to the heart rate at rest and during isometric and dynamic exercise in young healthy men.

G Nyberg.   

Abstract

Six young healthy males received on four different occasions 0.4 mg/kg i.v. of propranolol. 0.04 mg/kg i.v. of atropine, atropine following propranolol or saline. heart rate and blood pressure were recorded at rest (supine, sitting, and standing) and during isometric and dynamic exercise. On the basis of heart rate changes under the influence of drugs, the sympathetic contribution to heart rate was 25% at supine rest, 33% in the standing position, 45% during handgrip, and 74% during bicycle exercise that raised heart rate to 153/min. These results suggest that with increasing muscular activity the contribution of parasympathetic tone to heart rate decreases from about 75% at supine rest to about 25% at submaximal exercise. Extrapolation of the heart rate plots indicate that parasympathetic tone is virtually abolished at exercise loads resulting in a heart rate of about 200 beats/min.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6173524     DOI: 10.1097/00005344-198111000-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  4 in total

1.  The influence of cilazapril on indices of autonomic function in normotensives and hypertensives.

Authors:  H L Elliott; A A Ajayi; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

2.  Effects of atropine on left ventricular volumes and ejection and filling rates at rest and during exercise.

Authors:  H Kelbaek; J Marving; K Hvid-Jacobsen; S L Nielsen
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

3.  Heart rate control in hypertensive patients treated by captopril.

Authors:  A Sturani; C Chiarini; E Degliesposti; A Santoro; A Zuccalà; P Zucchelli
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

4.  Vagal blockade suppresses the phase I heart rate response but not the phase I cardiac output response at exercise onset in humans.

Authors:  Timothée Fontolliet; Aurélien Bringard; Alessandra Adami; Nazzareno Fagoni; Enrico Tam; Anna Taboni; Guido Ferretti
Journal:  Eur J Appl Physiol       Date:  2021-08-14       Impact factor: 3.078

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.